----
LeonaBio (LONA)
LeonaBio, Inc., clinical-stage biopharmaceutical company, engages in the development of novel therapeutics for high unmet medical needs, including treatment-res...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
- 52wk Low
- --
- Float Mkt Cap
- --
- Market Cap
- --
- P/ETTM
- --
- P/EDynamic
- --
- P/EStatic
- --
- EPSTTM
- --
- EPSDynamic
- --
- EPSStatic
- --
- BVPS
- --
- P/B
- --
- Circulating Supply
- --
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- --
- Min lot size
- --
- Currency
- --
LeonaBio Analyst Rating
View moreForecast & Rating
Oct 9, 2026Price forecast
$17.33258.13%
Forecast & RatingBuy
4analysts
- Strong buy50.00%
- Buy50.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 2
- Buy
- 2
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
News
benzinga_article · 12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga_article · 12 Health Care Stocks Moving In Monday's Intraday Session
Tip Ranks · LeonaBio Opens Warrant Exercise Window for New Capital
PUBT · LeonaBio says share purchase warrants become exercisable at USD 6.35 per share
